Send us Fan Mail

Learn more at CMTsummit.org

Your laptop can give you a thousand links about Charcot-Marie-Tooth disease, but it can’t give you certainty, context, or a hand on your shoulder when the fear spikes at 2 a.m. We dig into the newly released agenda for the HF Clinical Trial Readiness Summit Plus Retreat (April 16–18, 2026 in Ellicott City, Maryland) to answer a blunt question: why show up in person when the internet is overflowing with medical information?

We walk through the rare disease clinical trial problem set that keeps CMT therapies slow and scarce: small patient populations, highly variable symptoms, rigid legacy trial designs, and the need for FDA-ready endpoints. From new regulatory thinking to the push for a unified CMT data ecosystem, we explain what “trial readiness” really means and why it’s more than slides and jargon. We also unpack how biobanks and wearable studies turn real life into usable evidence by capturing continuous gait and fatigue signals that a short clinic visit will never see.

Then we shift to the parts of living with CMT that research often misses: breathing, hearing, eyesight, sleep, and the exhausting reality of fatigue. You’ll hear why a new validated CMT fatigue assessment matters for drug approval, and why practical sessions, respiratory tools, and hands-on demos like bracing, orthotics, adaptive driving, service dogs, and everyday gadgets can replace abstract anxiety with tactile clarity. Finally, we make the case that the most powerful “intervention” might be community itself, because isolation has measurable physical costs and connection can change the baseline.

If this resonates, subscribe, share this with someone navigating CMT, and leave a review so more people can find the conversation. What’s the one tool, symptom, or question you wish researchers would take more seriously?

Thanks for listening! Learn more at hnf-cure.org and subscribe for more updates on CMT research and advancements.

Send us Fan Mail

A slow-burning disease like Charcot Marie Tooth can fool even the best trials. Scores swing with sleep and stress, not biology, while tiny changes accumulate out of sight. We set out to replace guesswork with measurement and show how the right biomarkers can compress timelines, cut costs, and turn promising science into treatments that matter.

First, we unpack the measurement problem and why functional scales are too noisy for a disease that changes over years. Then we get concrete. MRI fat fraction reveals muscle-to-fat replacement in just 43 days, letting us see whether a therapy slows degeneration without waiting 18 months for a clinic score to budge. From there we move molecular: proteomics shows drops in extracellular matrix and neuronal development proteins alongside rising metabolic stress signals, reframing CMT as both a structural and metabolic disorder. That shift sets up a powerful case study—sorbitol accumulation traced to an enzyme defect—where a biomarker connected patients to a drug already in development for another condition.

We also highlight the rise of digital biomarkers that live where patients do. Wearables capture fatigue, drop foot, and real stair performance over weeks, producing real-world evidence that complements imaging and blood markers. None of this works without patient partnership, so we talk candidly about biobanks, why longitudinal samples are non-negotiable, and how skin cells reprogrammed into neurons enable personalized drug screens without invasive nerve biopsies. Finally, we tackle the big strategic question: will a universal marker like neurofilament light unlock progress across 100-plus genetic subtypes, or do we need a unique fingerprint for each?

If you care about faster trials, smarter endpoints, and bringing CMT treatments to the pharmacy shelf sooner, this deep dive is for you. Subscribe, share with someone in the CMT community, and leave a review with your take: master biomarker or many subtype markers?

Ways to take action now

1) Donate blood at an HNF Roadshow:
You can donate blood for biomarker research at an HNF Roadshow near you. Click on the “Location” tab to view 2026 dates and sites:

2) Join Studies & Donate blood at the CMT Summit + Retreat:
Attending the Summit? You can also donate blood on-site to support HNF’s biobank and biomarker discovery efforts—helping accelerate progress toward FDA-qualified measures and future treatments.

3) Join or update GRIN:
If you’re already in the GRIN Registry, please log in and complete any annual updates—every data point strengthens the research.

Watch webinar

Thanks for listening! Learn more at hnf-cure.org and subscribe for more updates on CMT research and advancements.

Send us Fan Mail

If resilience feels like a buzzword, consider this a reset. We explore a lived-in roadmap shaped by the Charcot-Marie-Tooth community, where change is constant and the goal isn’t to bounce back—it’s to move forward with smarter tools, stronger ties, and a lighter emotional weight. With Lily Sander, the 2025 MDA National Ambassador, and Estela Lugo from the Hereditary Neuropathy Foundation, we trace how connection creates “disabled joy,” a kind of relief that comes from being understood without translation. That recognition becomes fuel for action, whether it’s showing up at advocacy days, finding candid advice in digital groups, or letting positive representation shift your inner narrative.

Estela reframes resilience as the overlap of physical and emotional capacity. She names the hidden fall risks—blurred boundaries, comparison traps, people-pleasing—and offers a practical check-in using the Hawkins Scale of Emotions to move from heavy states like shame and fear toward courage, pride, and desire. We dig into fear management that’s actually usable: scout accessibility, use assistive tools without apology, and remember past wins as evidence. The message isn’t perfection; it’s honest capacity and self-grace, especially after stumbles. Purpose does the rest, turning the act of getting back up into a habit you can rely on.

We also get tactical with planning. Keep the vision, flex the route. If the dream is travel, adapt the method—cruises, companions, accessible gear, or remote work that funds the path. Service ties it all together: when you give back, fear shrinks, and pride grows, and your story helps someone else stand taller. We end with a memorable metaphor: the Alter-G treadmill that lifts body weight is also a lens for life. Community, flexible goals, and self-compassion are your emotional Ultra Gs—tools that reduce drag so you can keep moving. Subscribe, share this with a friend who needs a lift today, and tell us: what’s your Alter-G?

Watch this HNF + MDA webinar series on CMT and more here!

Connect with CMT Community at the 2026 CMT Summit & Retreat on 4/16-18 in Ellicott City, MD. Register here!

Thanks for listening! Learn more at hnf-cure.org and subscribe for more updates on CMT research and advancements.